Aloke Sarkar

674 total citations
20 papers, 492 citations indexed

About

Aloke Sarkar is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Aloke Sarkar has authored 20 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Epidemiology. Recurrent topics in Aloke Sarkar's work include Cell death mechanisms and regulation (4 papers), Virus-based gene therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Aloke Sarkar is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Virus-based gene therapy research (3 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Aloke Sarkar collaborates with scholars based in United States, India and Canada. Aloke Sarkar's co-authors include Varsha Gandhi, Jed G. Nuchtern, Michele F. Mitchell, Wei Hong, Tom Wright, Guillermo Tortolero‐Luna, Rebecca Richards‐Kortum, David Schottenfeld, Imran Ahmad and B.K. Bachhawat and has published in prestigious journals such as Blood, Clinical Cancer Research and The FASEB Journal.

In The Last Decade

Aloke Sarkar

19 papers receiving 477 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aloke Sarkar United States	14	273	107	105	100	69	20	492
Sherly Mosessian United States	8	423 1.5×	67 0.6×	144 1.4×	75 0.8×	59 0.9×	12	627
Tomoko Smyth United Kingdom	12	376 1.4×	56 0.5×	159 1.5×	202 2.0×	47 0.7×	33	631
Boaz Nachmias Israel	11	451 1.7×	42 0.4×	185 1.8×	112 1.1×	87 1.3×	57	697
Sonja Gudowius Germany	10	174 0.6×	96 0.9×	64 0.6×	259 2.6×	52 0.8×	16	478
Oliver Feyen Germany	16	250 0.9×	117 1.1×	176 1.7×	460 4.6×	80 1.2×	32	841
Robert Bartlett Germany	10	180 0.7×	84 0.8×	101 1.0×	283 2.8×	30 0.4×	12	672
Kyeong‐Man Hong South Korea	13	329 1.2×	154 1.4×	85 0.8×	44 0.4×	130 1.9×	33	606
Cristina Cirauqui Spain	11	311 1.1×	44 0.4×	89 0.8×	121 1.2×	79 1.1×	14	576
Chandtip Chandhasin United States	11	235 0.9×	43 0.4×	130 1.2×	84 0.8×	89 1.3×	22	566
M. Paredes-Espinoza Mexico	6	310 1.1×	122 1.1×	99 0.9×	116 1.2×	55 0.8×	7	527

Countries citing papers authored by Aloke Sarkar

Since Specialization

Citations

This map shows the geographic impact of Aloke Sarkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aloke Sarkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aloke Sarkar more than expected).

Fields of papers citing papers by Aloke Sarkar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aloke Sarkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aloke Sarkar. The network helps show where Aloke Sarkar may publish in the future.

Co-authorship network of co-authors of Aloke Sarkar

This figure shows the co-authorship network connecting the top 25 collaborators of Aloke Sarkar. A scholar is included among the top collaborators of Aloke Sarkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aloke Sarkar. Aloke Sarkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarkar, Aloke, et al.. (2023). Targeting MCL-1 protein to treat cancer: opportunities and challenges. Frontiers in Oncology. 13. 1226289–1226289. 32 indexed citations

Sarkar, Aloke, Stefan Hübner, Zhi Tan, et al.. (2022). Mechanisms of MCL-1 Protein Stability Induced by MCL-1 Antagonists in B-Cell Malignancies. Clinical Cancer Research. 29(2). 446–457. 13 indexed citations

Sarkar, Aloke & Varsha Gandhi. (2021). Correction to: Activation of ATM kinase by ROS generated during ionophore‑induced mitophagy in human T and B cell malignancies. Molecular and Cellular Biochemistry. 476(7). 2887–2887. 1 indexed citations

Sarkar, Aloke, Görkem Kısmalı, Burcu Aslan, et al.. (2020). AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 26(14). 3856–3867. 43 indexed citations

Sarkar, Aloke, Christine M. Stellrecht, Hima V. Vangapandu, et al.. (2020). Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica. 106(2). 495–512. 25 indexed citations

Sarkar, Aloke & Varsha Gandhi. (2020). Activation of ATM kinase by ROS generated during ionophore-induced mitophagy in human T and B cell malignancies. Molecular and Cellular Biochemistry. 476(1). 417–423. 12 indexed citations

Patel, Viralkumar, Kumudha Balakrishnan, Mark Douglas, et al.. (2016). Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199). Leukemia. 31(9). 1872–1881. 52 indexed citations

Sarkar, Aloke, Kumudha Balakrishnan, Jefferson W. Chen, et al.. (2015). Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphoma. Oncotarget. 7(3). 3461–3476. 7 indexed citations

Sarkar, Aloke, Mao Zhang, Shi‐He Liu, et al.. (2011). Serum response factor expression is enriched in pancreatic β cells and regulates insulin gene expression. The FASEB Journal. 25(8). 2592–2603. 13 indexed citations

10.

Sarkar, Aloke, et al.. (2007). Retroviral insertional activation of the Fli-3 locus in erythroleukemias encoding a cluster of microRNAs that convert Epo-induced differentiation to proliferation. Blood. 110(7). 2631–2640. 32 indexed citations

11.

Lee, Christina R., et al.. (2003). Friend virus-induced erythroleukemias: a unique and well-defined mouse model for the development of leukemia.. PubMed. 23(3A). 2159–66. 20 indexed citations

12.

Nehete, Pramod N., Emili Vela, Md. Moyazzem Hossain, et al.. (2002). A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antiviral Research. 56(3). 233–251. 30 indexed citations

13.

Sarkar, Aloke, et al.. (2001). Major Histocompatibility Complex–Restricted Lysis of Neuroblastoma Cells by Autologous Cytotoxic T Lymphocytes. Journal of Immunotherapy. 24(4). 305–311. 5 indexed citations

14.

Sarkar, Aloke & Jed G. Nuchtern. (2000). Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.. PubMed. 60(7). 1908–13. 41 indexed citations

15.

Mitchell, Michele F., Guillermo Tortolero‐Luna, Tom Wright, et al.. (1996). Cervical human papillomavirus infection and intraepithelial neoplasia: a review.. PubMed. 17–25. 89 indexed citations

16.

Sarkar, Aloke, et al.. (1994). Regulation of the expression of annexin VIII in acute promyelocytic leukemia. Blood. 84(1). 279–286. 36 indexed citations

17.

Sarkar, Aloke, et al.. (1994). Regulation of the expression of annexin VIII in acute promyelocytic leukemia. Blood. 84(1). 279–286. 4 indexed citations

18.

Ahmad, Imran, Aloke Sarkar, & B.K. Bachhawat. (1990). Liposomal amphotericin-B as a therapeutic measure to control experimental aspergillosis in BALB/c mice.. PubMed. 27(6). 370–4. 3 indexed citations

19.

Ahmad, Imran, Aloke Sarkar, & B.K. Bachhawat. (1989). Design of liposomes to improve delivery of amphotericin-B in the treatment of aspergillosis. Molecular and Cellular Biochemistry. 91(1-2). 85–90. 15 indexed citations

20.

Ahmad, Imran, Aloke Sarkar, & B.K. Bachhawat. (1989). Liposomal amphotericin-B in the control of experimental aspergillosis in mice: Part I--Relative therapeutic efficacy of free and liposomal amphotericin-B.. PubMed. 26(6). 351–6. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact